Fatigue & insomnia

Alzheimer’s disease (or fuzzy thinking)? —
References & further reading

References

1 Tavee, J., & Sweeney, P. 07/15/2006. Alzheimer’s.   www.clevelandclinicmeded.com/diseasemanagement/   neurology/alzheimers/alzheimers.htm

2 Zhang, H., et al. 2004. Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular beta-amyloid-(1-40) infused rats and human embryonic kidney 293 Swedish mutant cells. Neurosci. Lett., 360 (1–2), 21–24.

  Bai, D., et al. 2000. Huperzine A, a potential therapeutic agent for treatment of Alzheimer’s disease. Curr. Med. Chem., 7 (3), 355–374. Review.

  Ved, H. et al. 1997. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. Neuroreport, 8 (4), 963–968.

  For more information or to join a study currently underway on huperzine A in Alzheimer’s disease, visit the National Institutes of Health Clinical Trials webpage.

Further reading

For more information on Alzheimer’s, visit the following websites:


Return to:

Alzheimer’s disease

 

Original Publication Date: 10/10/2006
Last Modified: 02/16/2010
Principal Author: Marcella Sweet

Your Personal Program
Your Stories

"...I like myself better than this."

After a serious car accident, Helga, 35, started on a downward spiral. Not only was she gaining weight, but she soon found she had trouble with her thyroid, her blood pressure, and her cholesterol. She cared about herself too much to let these health problems continue and found Women to Women for help. Read about her tremendous success with our Personal Program.

Read this Story | All Stories



Questions? Call us at

1-800-798-7902

We're here to listen and help.